Hospitals that join a pricing database are able to reduce the negotiated prices they pay to medical technology companies.
L D I R E S E A R C H B R I E F
largest purchase volumes; they saved about $70 per stent.
These price effects are driven by increased likelihood of renegotiation and by larger price decreases when hospitals renegotiate. The findings suggest that benchmarking works by solving the asymmetric information problem and helping hospitals learn about suppliers; its effect on the relationship between hospitals and their negotiators is less clear.
Overall, by obtaining this price information, hospitals were able to achieve 26 percent of the savings that would have occurred if prices were set at the average level.
The benchmarking database provided hospitals with information to help them identify high-volume products for which they were paying higher than average prices and could see significant savings in a renegotiation.
THE IMPLICATIONS
Price transparency has been discussed as a way to reduce consumer health expenditures, but these new findings shed reducing "asymmetric information" about seller bargaining parameters (that is, not knowing the lowest price a seller would accept); and second, by helping hospitals solve the "agency problem" with their procurement negotiators (that is, allowing hospitals to monitor negotiator performance and restructure financial incentives). Taking coronary stents as their example, the authors look at whether hospitals that join a price benchmarking database, which contains average pricing based on data submitted by member hospitals, can achieve savings in future negotiations with suppliers.
THE FINDINGS
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